Subcutaneous use, 1 ml dose per vaccination.
Dogs can be vaccinated from the age of 6 weeks onwards.
Allow the vaccine to reach room temperature (15 °C – 25 °C) before use.
Shake well before each administered dose. Avoid introduction of contamination by using a clean needle for each administered dose.
Primary vaccination:
Two vaccinations with an interval of 4 weeks.
Re-vaccination:
A single vaccination, administered 7 months after primary vaccination with this vaccine, is sufficient to maintain protection against Bordetella bronchiseptica for a further year. Thereafter, a single vaccination should be administered, annually. In case re-vaccination at 7 months is missed, a single vaccination within 12 months after primary vaccination is sufficient to extend protection against Bordetella bronchiseptica for a further year.
This vaccine can also be used for re-vaccination in a schedule where Canigen KC has been used for primary vaccination. A single vaccination, administered one year after primary vaccination with Canigen KC, is sufficient to prolong immunity against Bordetella bronchiseptica for another year.
Re-vaccination after primary vaccination with Canigen KC:
One vaccination, annually.
For associated use:
When this vaccine is administered in associated use (i.e. not mixed) with another vaccine of the Canigen series as indicated, the vaccines should be given subcutaneously at the same time, at a different site. Dogs should not be younger than the minimum age recommended for the other Canigen vaccine, as stated in the respective product information.